High time to omit oxygen therapy in ST elevation myocardial infarction
- PMID: 30342466
- PMCID: PMC6196022
- DOI: 10.1186/s12873-018-0187-0
High time to omit oxygen therapy in ST elevation myocardial infarction
Abstract
Supplemental oxygen (O2) therapy in patients with chest pain has been a cornerstone in the treatment of suspected myocardial infarction (MI). Recent randomized controlled trials have, however, shown that supplemental O2 therapy has no positive nor negative effects on cardiovascular functions, mortality, morbidity or pain in normoxic patients with suspected MI and foremost patients with ST Elevation Myocardial Infarction (STEMI). O2 therapy in normoxic STEMI patients should therefore be omitted. More studies are needed in discussing hemodynamically unstable STEMI patients, as well as patients with non-STEMI, unstable angina and other emergency conditions.
Keywords: Emergency medicine; Oxygen; Oxygen therapy; Pathology; Physiology; ST elevation myocardial infarction; STEMI.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
Dr. Khoshnood have authored several articles on the role of supplemental O2 therapy in patients with myocardial infarction and STEMI. Dr. Khoshnood is also an Associate Editor at the BMC Emergency Medicine.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Group ESCSD. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2018:ehy462. - PubMed
-
- Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38(11):774–784. - PubMed
-
- Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, Fleischmann C, Werner GS, Olbrich HG, Ott R, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065–1074. doi: 10.1093/eurheartj/ehy004. - DOI - PMC - PubMed
-
- O'Gara Patrick T., Kushner Frederick G., Ascheim Deborah D., Casey Donald E., Chung Mina K., de Lemos James A., Ettinger Steven M., Fang James C., Fesmire Francis M., Franklin Barry A., Granger Christopher B., Krumholz Harlan M., Linderbaum Jane A., Morrow David A., Newby L. Kristin, Ornato Joseph P., Ou Narith, Radford Martha J., Tamis-Holland Jacqueline E., Tommaso Carl L., Tracy Cynthia M., Woo Y. Joseph, Zhao David X. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary. Journal of the American College of Cardiology. 2013;61(4):485–510. doi: 10.1016/j.jacc.2012.11.018. - DOI - PubMed
-
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical